PET in generalized anxiety disorder

Joseph C. Wu, Monte S. Buchsbaum, Tamara G. Hershey, Erin Hazlett, Nancy Sicotte, James Johnson

Research output: Contribution to journalArticle

159 Citations (Scopus)

Abstract

Positron emission tomography (PET) measurements of cerebral glucose use were made in 18 patients with generalized anxiety disorder (GAD) during a passive viewing task off medication, and an active vigilance viewing task before and after medication or placebo treatment. In the passive viewing task, patients with GAD were compared with 15 normal controls. A significant difference in pattern of absolute brain was found. Patients showed lower absolute metabolic rates in basal ganglia and white matter. Relative metabolism was increased in the left inferior area 17 in the occipital lobe, right posterior temporal lobe, and the right precentral frontal gyrus. Significant left-right asymmetry of the parahippocampal gyri was not found in patients with GAD. An active vigilance task resulted in activation of relative basal ganglia metabolism in patients. Benzodiazepine therapy resulted in decreases in absolute metabolic rates for cortical surface, limbic system, and basal ganglia and was not associated with normalization of patterns of glucose metabolism. Change in anxiety scores was significantly correlated with change in limbic system and basal ganglia for the placebo group. The normal-anxious difference in the basal ganglia and the change seen in this region after benzodiazepine treatment are suggestive of a role in anxiety for this structure.

Original languageEnglish (US)
Pages (from-to)1181-1199
Number of pages19
JournalBiological Psychiatry
Volume29
Issue number12
DOIs
StatePublished - Jun 15 1991
Externally publishedYes

Fingerprint

Basal Ganglia
Anxiety Disorders
Positron-Emission Tomography
Limbic System
Benzodiazepines
Anxiety
Placebos
Glucose
Basal Metabolism
Occipital Lobe
Parahippocampal Gyrus
Frontal Lobe
Temporal Lobe
Therapeutics
Brain

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Wu, J. C., Buchsbaum, M. S., Hershey, T. G., Hazlett, E., Sicotte, N., & Johnson, J. (1991). PET in generalized anxiety disorder. Biological Psychiatry, 29(12), 1181-1199. https://doi.org/10.1016/0006-3223(91)90326-H

PET in generalized anxiety disorder. / Wu, Joseph C.; Buchsbaum, Monte S.; Hershey, Tamara G.; Hazlett, Erin; Sicotte, Nancy; Johnson, James.

In: Biological Psychiatry, Vol. 29, No. 12, 15.06.1991, p. 1181-1199.

Research output: Contribution to journalArticle

Wu, JC, Buchsbaum, MS, Hershey, TG, Hazlett, E, Sicotte, N & Johnson, J 1991, 'PET in generalized anxiety disorder', Biological Psychiatry, vol. 29, no. 12, pp. 1181-1199. https://doi.org/10.1016/0006-3223(91)90326-H
Wu JC, Buchsbaum MS, Hershey TG, Hazlett E, Sicotte N, Johnson J. PET in generalized anxiety disorder. Biological Psychiatry. 1991 Jun 15;29(12):1181-1199. https://doi.org/10.1016/0006-3223(91)90326-H
Wu, Joseph C. ; Buchsbaum, Monte S. ; Hershey, Tamara G. ; Hazlett, Erin ; Sicotte, Nancy ; Johnson, James. / PET in generalized anxiety disorder. In: Biological Psychiatry. 1991 ; Vol. 29, No. 12. pp. 1181-1199.
@article{0e66aaf7b3fd405fa79aabbd86e548aa,
title = "PET in generalized anxiety disorder",
abstract = "Positron emission tomography (PET) measurements of cerebral glucose use were made in 18 patients with generalized anxiety disorder (GAD) during a passive viewing task off medication, and an active vigilance viewing task before and after medication or placebo treatment. In the passive viewing task, patients with GAD were compared with 15 normal controls. A significant difference in pattern of absolute brain was found. Patients showed lower absolute metabolic rates in basal ganglia and white matter. Relative metabolism was increased in the left inferior area 17 in the occipital lobe, right posterior temporal lobe, and the right precentral frontal gyrus. Significant left-right asymmetry of the parahippocampal gyri was not found in patients with GAD. An active vigilance task resulted in activation of relative basal ganglia metabolism in patients. Benzodiazepine therapy resulted in decreases in absolute metabolic rates for cortical surface, limbic system, and basal ganglia and was not associated with normalization of patterns of glucose metabolism. Change in anxiety scores was significantly correlated with change in limbic system and basal ganglia for the placebo group. The normal-anxious difference in the basal ganglia and the change seen in this region after benzodiazepine treatment are suggestive of a role in anxiety for this structure.",
author = "Wu, {Joseph C.} and Buchsbaum, {Monte S.} and Hershey, {Tamara G.} and Erin Hazlett and Nancy Sicotte and James Johnson",
year = "1991",
month = "6",
day = "15",
doi = "10.1016/0006-3223(91)90326-H",
language = "English (US)",
volume = "29",
pages = "1181--1199",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "12",

}

TY - JOUR

T1 - PET in generalized anxiety disorder

AU - Wu, Joseph C.

AU - Buchsbaum, Monte S.

AU - Hershey, Tamara G.

AU - Hazlett, Erin

AU - Sicotte, Nancy

AU - Johnson, James

PY - 1991/6/15

Y1 - 1991/6/15

N2 - Positron emission tomography (PET) measurements of cerebral glucose use were made in 18 patients with generalized anxiety disorder (GAD) during a passive viewing task off medication, and an active vigilance viewing task before and after medication or placebo treatment. In the passive viewing task, patients with GAD were compared with 15 normal controls. A significant difference in pattern of absolute brain was found. Patients showed lower absolute metabolic rates in basal ganglia and white matter. Relative metabolism was increased in the left inferior area 17 in the occipital lobe, right posterior temporal lobe, and the right precentral frontal gyrus. Significant left-right asymmetry of the parahippocampal gyri was not found in patients with GAD. An active vigilance task resulted in activation of relative basal ganglia metabolism in patients. Benzodiazepine therapy resulted in decreases in absolute metabolic rates for cortical surface, limbic system, and basal ganglia and was not associated with normalization of patterns of glucose metabolism. Change in anxiety scores was significantly correlated with change in limbic system and basal ganglia for the placebo group. The normal-anxious difference in the basal ganglia and the change seen in this region after benzodiazepine treatment are suggestive of a role in anxiety for this structure.

AB - Positron emission tomography (PET) measurements of cerebral glucose use were made in 18 patients with generalized anxiety disorder (GAD) during a passive viewing task off medication, and an active vigilance viewing task before and after medication or placebo treatment. In the passive viewing task, patients with GAD were compared with 15 normal controls. A significant difference in pattern of absolute brain was found. Patients showed lower absolute metabolic rates in basal ganglia and white matter. Relative metabolism was increased in the left inferior area 17 in the occipital lobe, right posterior temporal lobe, and the right precentral frontal gyrus. Significant left-right asymmetry of the parahippocampal gyri was not found in patients with GAD. An active vigilance task resulted in activation of relative basal ganglia metabolism in patients. Benzodiazepine therapy resulted in decreases in absolute metabolic rates for cortical surface, limbic system, and basal ganglia and was not associated with normalization of patterns of glucose metabolism. Change in anxiety scores was significantly correlated with change in limbic system and basal ganglia for the placebo group. The normal-anxious difference in the basal ganglia and the change seen in this region after benzodiazepine treatment are suggestive of a role in anxiety for this structure.

UR - http://www.scopus.com/inward/record.url?scp=0025737831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025737831&partnerID=8YFLogxK

U2 - 10.1016/0006-3223(91)90326-H

DO - 10.1016/0006-3223(91)90326-H

M3 - Article

C2 - 1888800

AN - SCOPUS:0025737831

VL - 29

SP - 1181

EP - 1199

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 12

ER -